Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Jichang Hu"'
Autor:
Zhendong Xu, Jichang Hu, Zhen Wei, Yu Lei, Henok Kessete Afewerky, Yang Gao, Lu Wan, Longfei Li, Ling Lei, Yi Liu, Fang Huang, Tong Yu, Jian‐Zhi Wang, Hong‐Lian Li, Rong Liu, Xiaochuan Wang
Publikováno v:
MedComm, Vol 5, Iss 4, Pp n/a-n/a (2024)
Abstract Senile plaque, composed of amyloid β protein (Aβ) aggregates, is a critical pathological feature in Alzheimer's disease (AD), leading to cognitive dysfunction. However, how Aβ aggregates exert age‐dependent toxicity and temporal cogniti
Externí odkaz:
https://doaj.org/article/62d0d1779abc4c23b5ba94d28a53baad
Autor:
Zhen Wei, Kuan Zeng, Jichang Hu, Xing Li, Fang Huang, Bin Zhang, Jian-Zhi Wang, Rong Liu, Hong-Lian Li, Xiaochuan Wang
Publikováno v:
Cell Death and Disease, Vol 13, Iss 8, Pp 1-12 (2022)
Abstract Normal Tau promotes the assembly and stabilization of microtubules, thus, maintaining axon transport. In Alzheimer’s disease (AD), Tau aggregation causes it to lose these above-mentioned functions. However, the molecular mechanism leading
Externí odkaz:
https://doaj.org/article/eadd0c00a25043dd80d43e86fdac766a
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
N6-methyladenosine (m6A) is the most common form of mRNA modification, and is dynamically regulated by the m6A RNA methylation regulators. However, little is known about m6A in gastric cancer. The aim of this work is to investigate the effects of m6A
Externí odkaz:
https://doaj.org/article/818e1b14713846d68c3cede8020711a6
Publikováno v:
International Journal of Surgery. 109:21-31
Publikováno v:
Current Problems in Cardiology. 48:101551
Antihypertensive drugs are commonly used in cardiovascular diseases (CVD), less is known about the comparative effectiveness of different antihypertensive drugs on stroke events in CVD patients. We searched MEDLINE, EMBASE, the Cochrane Library, and
Publikováno v:
Aging. 11:4463-4477
Publikováno v:
Neuroscience. 337:191-199
Maternally expressed gene 3 (MEG3) is suggested to function as a long non-coding RNA (lncRNA) and to play roles in various human cancers. However, the functional properties of MEG3 in ischemic stroke remain unknown. Here, we report that expression of
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
N6-methyladenosine (m6A) is the most common form of mRNA modification, and is dynamically regulated by the m6A RNA methylation regulators. However, little is known about m6A in gastric cancer. The aim of this work is to investigate the effects of m6A
Publikováno v:
Frontiers in Oncology
N6-methyladenosine (m6A) is the most common form of mRNA modification, and is dynamically regulated by the m6A RNA methylation regulators. However, little is known about m6A in gastric cancer. The aim of this work is to investigate the effects of m6A